Child's Nervous System

, Volume 26, Issue 8, pp 1097–1102 | Cite as

Intrathecal baclofen therapy for spasticity of cerebral origin—does the position of the intrathecal catheter matter?

  • Gnanamurthy SivakumarEmail author
  • Yoong Yap
  • Mekidm Tsegaye
  • Michael Vloeberghs
Original Paper



To assess the correlation between the position of the intrathecal baclofen therapy catheter with the clinical outcome and response to the spasticity.

Methods and Results

A prospective cohort study was done by reviewing the paediatric group of patients with spasticity of cerebral origin who had insertion of a programmable baclofen pump for intrathecal administration in the last 10 years (August 1998 to September 2007). A total of 190 procedures were carried out in 166 patients, under a single paediatric neurosurgeon, with an age range of 18 months–16 years (mean 8.75 years) with follow up of 1–10 years (mean 5 years). The routine post-operative X-rays, which were done as per protocol, were reviewed, and the position of the intrathecal catheter tip was documented in relation to the vertebral bodies. The maintenance intrathecal baclofen dose was 25 µgms to 1,000 µgms (mean 255.8 µgms) based on the clinical response to spasticity. Statistical analysis was carried out to assess the correlation of the position of the tip of the intrathecal catheter with the outcome in spasticity based on GMFCS (Gross Motor Function Classification System) and Ashworth score.


In our series, there was no statistically significant correlation between the position of the intrathecal catheter and the clinical response to the spasticity.


Spasticity Cerebral palsy Intrathecal baclofen therapy Intrathecal catheter position 



We would like to thank Ruth Haskins, Medical Secretary, for collecting the intrathecal baclofen pumps data prospectively. No financial support was given for this work, and there is no conflict of interest.


We confirm that there was no form of funding received for this work from any of the organisations.

The authors declare that they have no conflict of interest.


  1. 1.
    Albright AL, Turner M, Pattisapu JV (2006) Best-practice surgical techniques for intrathecal baclofen therapy. J Neurosurg 104(4 Suppl):233–239PubMedGoogle Scholar
  2. 2.
    Bensmail D, Ward AB, Wissel J, Motta F, Saltuari L, Lissens J, Cros S, Beresniak A (2009) Cost-effectiveness modelling of intrathecal baclofen therapy versus other interventions for disabling spasticity. Neurorehabilitation and Neural Repair. Feb: 1–7Google Scholar
  3. 3.
    Borowski A, Littleton AG, Borkhuu B, Presedo A, Shah S, Dabney KW, Lyons S, McMannus M, Miller F (2010) Complications of intrathecal baclofen pump therapy in pediatric patients. J Pediatr Orthop 30(1):76–80PubMedGoogle Scholar
  4. 4.
    Brochard S, Remy-Neris O, Filipetti P, Bussel B (2009) Intrathecal baclofen infusion for ambulant children with cerebral palsy. Pediatr Neurol 40:265–270CrossRefPubMedGoogle Scholar
  5. 5.
    Burns AS, Meythaler JM (2001) Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 39(8):413–419CrossRefPubMedGoogle Scholar
  6. 6.
    Dickerman RD, Schneider SJ (2002) Recurrent intrathecal baclofen pump catheter leakage: a surgical observation with recommendations. J Pediatr Surg 37(6):E17CrossRefPubMedGoogle Scholar
  7. 7.
    Dickerman RD, Stevens QE, Schneider SJ (2003) The role of surgical placement and pump orientation in intrathecal pump system failure: a technical report. Pediatr Neurosurg 38(2):107–109CrossRefPubMedGoogle Scholar
  8. 8.
    Dziurzynski K, McLeish D, Ward M, Iskandar BJ (2006) Placement of baclofen pumps through the foramen magnum and upper cervical spine. Childs Nerv Syst 22(3):270–273, Epub 2005 Jun 11CrossRefPubMedGoogle Scholar
  9. 9.
    Fitzgerald JJ, Tsegaye M, Vloeberghs MH (2004) Treatment of childhood spasticity of cerebral origin with intrathecal baclofen: a series of 52 cases. Br J Neurosurg 18(3):240–245CrossRefPubMedGoogle Scholar
  10. 10.
    Grabb PA, Guin-Renfroe S, Meythaler JM (1999) Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurgery 45(4):833–836, discussion 836–837CrossRefPubMedGoogle Scholar
  11. 11.
    Guillaume D, Van Havenbergh A, Vloeberghs M, Vidal J, Roeste G (2005) A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity. Arch Phys Med Rehabil 86(11):2165–2171CrossRefPubMedGoogle Scholar
  12. 12.
    Hoving MA, van Raak EPM, Spincemaille GHJJ, van Kranen-Mastenbroek VHJM, van Kleef M, Gorter JW, Vles JSH (2009) Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Eur J Paediatr Neurol 13:247–256CrossRefPubMedGoogle Scholar
  13. 13.
    Hoving MA, van Raak EPM, Spincemaille GHJJ, Palmans LJ, Becher JG, Vles JSH (2009). Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial. Eur J Paediatr Neurol (13):240–246Google Scholar
  14. 14.
    Hugenholtz H, Nelson RF, Dehoux E (1993) Intrathecal baclofen—the importance of catheter position. Can J Neurol Sci 20:165–167PubMedGoogle Scholar
  15. 15.
    Loubser PG, Narayan RK (1993) Effect of subarachnoid catheter position on the efficacy of intrathecal baclofen for spinal spasticity. Anesthesiology 79(3):611–614CrossRefPubMedGoogle Scholar
  16. 16.
    McCall TD, MacDonald JD (2006) Cervical catheter tip placement for intrathecal baclofen administration. Neurosurgery 59(3):634–640, discussion 634–640CrossRefPubMedGoogle Scholar
  17. 17.
    Plassat R, Perrouin Verbe B, Menei P, Menegalli D, Mathé JF, Richard I (2004) Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients. Spinal Cord 42(12):686–693CrossRefPubMedGoogle Scholar
  18. 18.
    Ramstad K, Jahnsen R, Lofterod B, Skjeldal OH (2009) Continuous intrathecal baclofen therapy in children with cerebral palsy—when does improvement emerge? Acta Paediatrica :1–5Google Scholar
  19. 19.
    Rawlins PK (2004) Intrathecal baclofen therapy over 10 years. J Neurosci Nurs 36(6):322–327CrossRefPubMedGoogle Scholar
  20. 20.
    Ross DA, Byers C, Hall T (2005) A novel approach to prevent repeated catheter migration in a patient with a baclofen pump: a case report. Arch Phys Med Rehabil 86(5):1060–1061CrossRefPubMedGoogle Scholar
  21. 21.
    Russman BS (2008) Continuous intrathecal baclofen infusion for intractable spastic cerebral palsy—is it worth it? Nat Clin Pract Neuro 4(9):476–477CrossRefGoogle Scholar
  22. 22.
    Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 79(6):536–541CrossRefPubMedGoogle Scholar
  23. 23.
    Vloeberghs M, Keetley R, Morton R (2005) Intrathecal baclofen in the management of spasticity due to cerebral palsy. Pediatr Rehabil 8(3):172–179PubMedGoogle Scholar
  24. 24.
    Ward A, Hayden S, Dexter M, Scheinberg A (2009) Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paediatr Child Health 45:720–726CrossRefPubMedGoogle Scholar
  25. 25.
    Woon K, Tsegaye M, Vloeberghs MH (2007) The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Br J Neurosurg 21(4):355–358CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Gnanamurthy Sivakumar
    • 1
    Email author
  • Yoong Yap
    • 2
  • Mekidm Tsegaye
    • 3
  • Michael Vloeberghs
    • 1
  1. 1.Nottingham University HospitalNottinghamUK
  2. 2.Newcastle General HospitalNewcastle upon TyneUK
  3. 3.The Walton NHS trust for Neurosurgery & NeurologyLiverpoolUK

Personalised recommendations